Low-dose Interleukin-2: Biology and therapeutic prospects in rheumatoid arthritis
R Wu, N Li, X Zhao, T Ding, H Xue, C Gao, X Li… - Autoimmunity …, 2020 - Elsevier
Rheumatoid arthritis (RA) is a chronic aggressive arthritis that is characterized with systemic
inflammation response, the production of abnormal antibodies, and persistent synovitis. One …
inflammation response, the production of abnormal antibodies, and persistent synovitis. One …
A primer on cytokines
Cytokines are pleiotropic polypeptides that control the development of and responses
mediated by immune cells. Cytokine classification predominantly relies on [1] the target …
mediated by immune cells. Cytokine classification predominantly relies on [1] the target …
[HTML][HTML] Antibodies to interleukin-2 elicit selective T cell subset potentiation through distinct conformational mechanisms
Summary Interleukin-2 (IL-2) is a pleiotropic cytokine that regulates immune cell
homeostasis and has been used to treat a range of disorders including cancer and …
homeostasis and has been used to treat a range of disorders including cancer and …
Interleukin-2: old and new approaches to enhance immune-therapeutic efficacy
P Dhupkar, N Gordon - Immunotherapy, 2017 - Springer
Abstract Interleukin-2 (IL-2) is a very well-known cytokine that has been studied for the past
35 years. It plays a major role in the growth and proliferation of many immune cells such NK …
35 years. It plays a major role in the growth and proliferation of many immune cells such NK …
Blocking IL-2 signal in vivo with an IL-2 antagonist reduces tumor growth through the control of regulatory T cells
T Carmenate, Y Ortíz, M Enamorado… - The Journal of …, 2018 - journals.aai.org
IL-2 is critical for peripheral tolerance mediated by regulatory T (Treg) cells, which represent
an obstacle for effective cancer immunotherapy. Although IL-2 is important for effector (E) T …
an obstacle for effective cancer immunotherapy. Although IL-2 is important for effector (E) T …
CD4+ T cells support polyfunctionality of cytotoxic CD8+ T cells with memory potential in immunological control of tumor
N Imai, I Tawara, M Yamane, D Muraoka… - Cancer …, 2020 - Wiley Online Library
Polyfunctionality/multifunctionality of effector T cells at the single cell level has been shown
as an important parameter to predict the quality of T cell response and immunological …
as an important parameter to predict the quality of T cell response and immunological …
Probing antibody surface density and analyte antigen incubation time as dominant parameters influencing the antibody-antigen recognition events of a non-faradaic …
J Zorea, RP Shukla, M Elkabets… - Analytical and bioanalytical …, 2020 - Springer
Electrochemical sensors based on antibody-antigen recognition events are commonly used
for the rapid, label-free, and sensitive detection of various analytes. However, various …
for the rapid, label-free, and sensitive detection of various analytes. However, various …
New therapeutic strategies based on IL-2 to modulate Treg cells for autoimmune diseases
L Xu, X Song, L Su, Y Zheng, R Li, J Sun - International …, 2019 - Elsevier
Abstract Interleukin-2 (IL-2) is a multifunctional cytokine in immune regulation. It is essential
for the differentiation, expansion and stability of CD25+ Foxp3+ regulatory T (Treg) cells …
for the differentiation, expansion and stability of CD25+ Foxp3+ regulatory T (Treg) cells …
IL-2/anti-IL-2 mAb immunocomplexes: A renascence of IL-2 in cancer immunotherapy?
J Tomala, M Kovar - Oncoimmunology, 2016 - Taylor & Francis
The in vivo biological activity of IL-2 can be dramatically increased by complexing with anti-
IL-2 mAb. Moreover, IL-2/anti-IL-2 mAb immunocomplexes selectively stimulate different …
IL-2 mAb. Moreover, IL-2/anti-IL-2 mAb immunocomplexes selectively stimulate different …
Increasing the biological activity of IL-2 and IL-15 through complexing with anti-IL-2 mAbs and IL-15Rα-Fc chimera
P Votavova, J Tomala, M Kovar - Immunology letters, 2014 - Elsevier
Abstract IL-2 and IL-15 are structurally relative cytokines that share two receptor subunits,
CD132 (γ c chain) and CD122 (β chain). However, the expression pattern and physiological …
CD132 (γ c chain) and CD122 (β chain). However, the expression pattern and physiological …